ArticleOrphanet journal of rare diseases2025
Mitochondrial neurogastrointestinal encephalomyopathy in china: a novel TYMP variant and comprehensive clinical-genetic insights.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of a Homozygous TYMP c.131G>C Variant With MNGIE in a Chinese Pedigree: Insights From Genetic Analysis and Computational Modeling.Molecular genetics & genomic medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMitochondrial neurogastrointestinal encephalopathy (MNGIE) is a rare autosomal recessive disorder caused by variants in the TYMP gene, which encodes thymidine phosphorylase (TP). It is characterized by multisystem involvement, with prominent gastrointestinal, neurological, and systemic manifestations that typically exhibit progressive worsening over time.
methodsWe characterized a multigenerational MNGIE family through comprehensive proband analysis, identifying compound heterozygous TYMP variants (c.131G > C, p.Arg44Pro and c.1268T>G, p.Leu423Arg in trans) as the molecular basis of disease. Extended family testing for genetic counseling confirmed no secondary pathogenic variants. Muscle biopsies were analyzed using comprehensive staining techniques. Genomic analysis involved next-generation sequencing (NGS) of the proband's DNA and Sanger sequencing of family members' DNA to confirm variants. In silico analysis utilized bioinformatics tools and protein modeling to predict pathogenicity and assess structural impacts, with variant classification adhering to American College of Medical Genetics and Genomics(ACMG) guidelines. Additionally, a literature review of Chinese MNGIE cases was conducted to contextualize the findings.
resultsThe proband exhibited characteristic MNGIE features, including gastrointestinal dysmotility, diffuse leukoencephalopathy on brain MRI (magnetic resonance imaging), and electrophysiologically confirmed peripheral neuropathy. Muscle biopsy revealed ragged red fibers, cytochrome c oxidase-deficient fibers, and enhanced succinate dehydrogenase activity in blood vessels, consistent with mitochondrial dysfunction. Genetic analysis identified a novel TYMP variant (c.1268T > G, p.Leu423Arg) and a known variant (c.131G > C, p.Arg44Pro) in the proband, both classified as likely pathogenic according to ACMG guidelines. Molecular analysis of other 11 family members detected heterozygous carriers of either the c.1268T > G or c.131G > C variant in six asymptomatic individuals. In silico analysis confirmed that both variants are highly conserved and likely pathogenic. Protein modeling revealed that both variants compromise structural integrity and conformation, impairing TP function. Homozygous or compound heterozygous missense variants were identified as the predominant genetic alterations in 16 Chinese MNGIE cases, with gastrointestinal and neurological symptoms being the most common clinical manifestations.
conclusionsThis study enriches the variant spectrum in Chinese patients, highlights the importance of early diagnosis prior to the onset of cachexia and irreversible tissue damage, and enhances the understanding of genetic heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.